Drug Shortage Report for AVAMYS
Report ID | 205521 |
Drug Identification Number | 02298589 |
Brand name | AVAMYS |
Common or Proper name | fluticasone furoate nasal spray |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | FLUTICASONE FUROATE |
Strength(s) | 27.5MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL NASAL |
Packaging size | 1x120 |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-09-25 |
Estimated end date | 2023-12-08 |
Actual end date | 2023-11-24 |
Shortage status | Resolved |
Updated date | 2023-11-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-09-29 | English | Compare |
v2 | 2023-09-29 | French | Compare |
v3 | 2023-11-08 | English | Compare |
v4 | 2023-11-08 | French | Compare |
v5 | 2023-11-22 | English | Compare |
v6 | 2023-11-22 | French | Compare |
v7 | 2023-11-24 | English | Compare |
v8 | 2023-11-24 | French | Compare |
v9 | 2023-11-25 | English | Compare |
Showing 1 to 9 of 9